Estrella Immunopharma Inc. (NASDAQ: ESLA) Stock Information | RedChip

Estrella Immunopharma Inc. (NASDAQ: ESLA)


$1.2500
+0.0788 ( +14.68% ) 17.0K

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Market Data


Open


$1.2500

Previous close


$1.1712

Volume


17.0K

Market cap


$42.37M

Day range


$1.0600 - $1.2350

52 week range


$0.6300 - $3.2300

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Jan 30, 2024

Latest News